Angel Martin-Mallo

CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome

F. Prósper, M. Juan, B. Paiva, 2021, medRxiv.

In vivo CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria

E. Salido, F. Prósper, M. E. Calleja-Cervantes, 2022, Molecular therapy. Methods & clinical development.

Generation of an induced pluripotent stem cell line (CIMAi001-A) from a compound heterozygous Primary Hyperoxaluria Type I (PH1) patient carrying p.G170R and p.R122* mutations in the AGXT gene.

E. Salido, F. Prósper, B. Beck, 2019, Stem Cell Research.

CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome

F. Prósper, M. Juan, B. Paiva, 2022, medRxiv.

Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia

J. Lasarte, M. E. Calleja-Cervantes, G. Abizanda, 2023, Frontiers in immunology.